Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |